-
1دورية أكاديمية
المؤلفون: Stathis, AnastasiosAff1, IDs10637022013263_cor1, Tolcher, Anthony W., Wang, Judy S., Renouf, Daniel J., Chen, Lin-Chi, Suttner, Leah H., Freshwater, Tomoko, Webber, Andrea L., Nayak, Tapan, Siu, Lillian L.
المصدر: Investigational New Drugs: Novel Anti-Cancer Therapeutics and Therapies. 41(3):380-390
-
2دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
3دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
4دورية أكاديمية
المؤلفون: Tolcher, Anthony W, Kurzrock, Razelle, Valero, Vincente, Gonzalez, Rene, Heist, Rebecca S, Tan, Antoinette R, Means-Powell, Julie, Werner, Theresa L, Becerra, Carlos, Wang, Chenxi, Leonowens, Cathrine, Kalyana-Sundaram, Shanker, Kleha, Joseph F, Gauvin, Jennifer, D’Amelio, Anthony M, Ellis, Catherine, Ibrahim, Nageatte, Yan, Li
المصدر: Cancer Chemotherapy and Pharmacology. 85(4)
مصطلحات موضوعية: Pharmacology and Pharmaceutical Sciences, Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Clinical Trials and Supportive Activities, Clinical Research, Cancer, Evaluation of treatments and therapeutic interventions, 6.2 Cellular and gene therapies, 6.1 Pharmaceuticals, Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Cohort Studies, Diamines, Dose-Response Relationship, Drug, Female, Follow-Up Studies, Humans, MAP Kinase Kinase 1, MAP Kinase Kinase 2, Male, Maximum Tolerated Dose, Melanoma, Middle Aged, Prognosis, Proto-Oncogene Proteins c-akt, Pyrazoles, Pyridones, Pyrimidinones, Tissue Distribution, Triple Negative Breast Neoplasms, Young Adult, AKT inhibitor, BRAF-wild type melanoma, MEK inhibitor, Trametinib, Triple-negative breast cancer, Uprosertib, Oncology & Carcinogenesis, Oncology and carcinogenesis, Pharmacology and pharmaceutical sciences
وصف الملف: application/pdf
URL الوصول: https://escholarship.org/uc/item/6c2779pg
-
5دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
6دورية أكاديمية
المؤلفون: Berlin, JordanAff1, Aff2, IDs10637022012177_cor1, Tolcher, Anthony W., Ding, Cliff, Whisenant, Jennifer G., Horak, Ivan D., Wood, Debra L., Nadler, Paul I., Hansen, Ulla Holm, Lantto, Johan, Skartved, Niels Jørgen Ø., Pedersen, Mikkel W., Patnaik, Amita
المصدر: Investigational New Drugs: Novel Anti-Cancer Therapeutics and Therapies. 40(3):586-595
-
7دورية أكاديمية
المؤلفون: Goldman, Jonathan W, Rosen, Lee S, Tolcher, Anthony W, Papadopoulos, Kyriakos, Beeram, Muralidhar, Shi, Peipei, Pitou, Celine, Bell, Robert, Kulanthaivel, Palaniappan, Zhang, Xuekui, Fink, Aaron, Chan, Edward M, Shahir, Ashwin, Farrington, Daphne, Patnaik, Amita
المصدر: Investigational New Drugs. 36(4)
مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Cancer, Patient Safety, Digestive Diseases, Clinical Trials and Supportive Activities, Clinical Research, 6.2 Cellular and gene therapies, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, Adult, Aged, Antineoplastic Agents, Biomarkers, Tumor, Dose-Response Relationship, Drug, Female, Humans, Male, Maximum Tolerated Dose, Middle Aged, Neoplasms, Protein Kinase Inhibitors, Treatment Outcome, p38 Mitogen-Activated Protein Kinases, p38 mitogen-activated protein kinase, Advanced cancer, Inhibitor, Pharmacology and Pharmaceutical Sciences, Oncology & Carcinogenesis, Oncology and carcinogenesis, Pharmacology and pharmaceutical sciences
وصف الملف: application/pdf
URL الوصول: https://escholarship.org/uc/item/8nd7m8tv
-
8دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
9دورية أكاديمية
المؤلفون: Bendell, Johanna C, Javle, Milind, Bekaii-Saab, Tanios S, Finn, Richard S, Wainberg, Zev A, Laheru, Daniel A, Weekes, Colin D, Tan, Benjamin R, Khan, Gazala N, Zalupski, Mark M, Infante, Jeffrey R, Jones, Suzanne, Papadopoulos, Kyriakos P, Tolcher, Anthony W, Chavira, Renae E, Christy-Bittel, Janna L, Barrett, Emma, Patnaik, Amita
المصدر: British Journal of Cancer. 116(5)
مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Clinical Research, Digestive Diseases, Clinical Trials and Supportive Activities, Cancer, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, Benzimidazoles, Drug Administration Schedule, Female, Humans, MAP Kinase Kinase 1, MAP Kinase Kinase 2, Male, Maximum Tolerated Dose, Neoplasms, Proto-Oncogene Proteins B-raf, Treatment Outcome, ras Proteins, binimetinib, MEK162, MEK inhibitor, gastrointestinal cancers, colorectal cancers, clinical trial, Public Health and Health Services, Oncology & Carcinogenesis, Oncology and carcinogenesis
وصف الملف: application/pdf
URL الوصول: https://escholarship.org/uc/item/8qt8k4th
-
10دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.